Author

Satish Kumar Reddy Noonepalle

Georgetown UniversityORCID 0000-0002-0346-3882Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

Cyril BařinkaiD· 2 shared Albert BatushanskyiD· 1 shared Alejandro Villagra· 1 shared Alejandro VillagraiD· 1 shared Barbora HavlínováiD· 1 shared Eyal ArbelyiD· 1 shared Fang Wu· 1 shared Gargi DasiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

Cyril BařinkaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

HDAC6 and SSAT2 orchestrate acetyllysine metabolism and protein homeostasis

Fang Wu, Santhosh Paramasivam, Satish Kumar Reddy Noonepalle, Albert Batushansky, Miroslava Vošahlíková, Alejandro Villagra, Cyril Bařinka, Eyal Arbely

The paper identifies HDAC6 and SSAT2 as enzymes regulating acetyllysine metabolism and protein homeostasis through opposing deacetylation and acetylation reactions.

bioRxiv · May 26, 2026 · PreprintBiochemistry

Targeting prostate cancer by new bispecific monocyte engager directed to prostate-specific membrane antigen

Gargi Das, J. Ptáček, Jana Campbell, Xintang Li, Barbora Havlínová, Satish Kumar Reddy Noonepalle, Alejandro Villagra, Cyril Bařinka, Zora Nováková

This paper describes the design and characterization of a bispecific monocyte engager targeting PSMA for prostate cancer immunotherapy, showing effective activation of monocytes and tumor cell elimination.

PLoS ONE · Mar 17, 2025Peer-reviewedBioengineering